EUVIMEDEUVIMED entdecken
Crossref

Restrain from Nootropics: A View Point

Nnodim Johnkennedy

International Journal of Stem Cells and Medicine · 2022

DOI: 10.58489/2836-5038/001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Stem Cells and Medicine, 2022. Verfasst von Nnodim Johnkennedy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nootropics are known as smart medications. They belong to a family of pharmaceuticals that have the ability to improve brain function. They are referred to as substances that improve memory or cognition. Nootropics on prescription are drugs with stimulating effects. They can lessen the effects of medical disorders like Alzheimer's disease, narcolepsy, and attention deficit hyperactivity disorder (ADHD) [1]. Nootropics also include over-the-counter medications that improve brain function or focus, such as caffeine and creatine. They do not treat illnesses, but they may have some impact on memory, thinking, or other mental processes [2].

Zitieren

APA

Johnkennedy, N. (2022). Restrain from Nootropics: A View Point. International Journal of Stem Cells and Medicine. https://doi.org/10.58489/2836-5038/001

Vancouver

Johnkennedy N. Restrain from Nootropics: A View Point. International Journal of Stem Cells and Medicine. 2022. doi:10.58489/2836-5038/001

BibTeX
@article{Johnkennedy2022,
  author = {Johnkennedy, Nnodim},
  title = {Restrain from Nootropics: A View Point},
  journal = {International Journal of Stem Cells and Medicine},
  year = {2022},
  doi = {10.58489/2836-5038/001}
}
Kostenlos starten →